California · Attorney-led · Clinician-informed
Forward-thinking, whole-person plans for inherited breast and ovarian cancer risk—from the first genetic report through family testing, preventive surgery, surgical menopause, recovery, and the legal realities around care.
This site provides education and describes attorney-led planning services. It does not diagnose, prescribe, or replace a licensed physician, surgeon, genetic counselor, menopause clinician, or pain specialist. Clinical recommendations and treatment must come from the appropriately licensed treating professional.
Each plan begins with the exact laboratory report, the person’s cancer and family history, current clinical guidance, personal priorities, and the legal or coverage constraints that may shape access. The output is a written decision file—not a generic checklist.
Prepare the gynecologic-oncology conversation around risk-reducing salpingo-oophorectomy, timing, fertility, pathology protocol, residual primary peritoneal risk, and why ultrasound or CA-125 is not a proven substitute for prevention.
Coordinate a breast-specialist review of enhanced screening and risk-reducing surgery, including the tradeoffs that statistics alone cannot resolve.
Who tests first, what exact test to order, and how the result changes care.
Symptoms, hormone options, bone, heart, sexual, urinary, sleep, and cognitive health.
Multimodal relief, rehabilitation, pelvic-floor care, palliative support, and escalation rules.
Records, coverage, appeals, leave, privacy, family authority, and decision documentation.
A mail-order panel is not a family strategy. Clinical genetic counseling connects the test to the pedigree, the laboratory report, the person most likely to yield an informative result, and the medical decisions that follow.
Obtain the complete germline report. Tumor testing can identify a BRCA change, but it does not by itself establish that the change was inherited.
When possible, a relative who has had a BRCA-associated cancer is generally the most informative person to test first. A genetics professional should select the panel.
Begin cascade testing with adult parents, siblings, and children, using the exact familial variant and expanding through the side of the family where it is found.
BRCA predictive testing is generally not recommended before age 18 because childhood risk-management strategies are not available. Adult timing should allow counseling before screening or prevention decisions are due.
A variant of uncertain significance is not a positive result. Management rests on personal and family history unless the variant is reclassified.
Preventive surgery can reduce risk, but it is irreversible and does not eliminate every future cancer risk. A sophisticated consultation addresses the procedure, the pathology, the body, and the years that follow.
Timing, fertility, RRSO, staged salpingectomy under study, pathology, residual risk
Gynecologic oncologistEnhanced screening, mastectomy choice, nipple-sparing candidacy, reconstruction, sensation
Breast + plastic surgeonsPersonal cancer history, receptors, uterus status, hormone and nonhormone options, monitoring
Menopause-trained physicianAnalgesia, nerve pain, mobility, lymphedema risk, pelvic floor, sleep, return to work
Pain + rehabilitation teamBefore ovaries are removed
Early loss of ovarian hormones can affect vasomotor symptoms, bone density, cardiovascular health, sexual function, genitourinary comfort, sleep, mood, and cognition. The plan should name who will manage each domain and when it will be reassessed.
Not a yes/no slogan. A licensed clinician should individualize systemic or local therapy by personal cancer history, receptor status, uterus status, age, symptoms, thrombotic and cardiovascular risk, and patient goals.
Prescription and nonprescription options, pelvic-floor care, sexual-health support, sleep treatment, and bone-protection strategies belong in the same review.
Set a schedule for bone, cardiovascular and metabolic health, symptoms, medication effects, breast risk, and quality of life.
Ten original, source-led guides organize the clinical questions, practical details, legal record, and recovery work that are often scattered across appointments.
Written for clarity and search visibility—without keyword stuffing, copied text, miracle claims, or pretending that education is a prescription.
Who should test first, germline versus tumor testing, cascade testing, VUS results, and how to prepare relatives without creating panic.
Open guide ↗The ovarian-first conversation: proven risk reduction, the ovary-preserving approach under study, pathology, residual risk, fertility, and surgical menopause.
Open guide ↗Compare mastectomy and reconstruction pathways, implant and autologous options, revision likelihood, nerve preservation, sensation, sexuality, and second opinions.
Open guide ↗What each test is for, when MRI guides a biopsy, why CT is not routine high-risk breast screening, and how ER, PR, HER2, grade, and stage shape treatment.
Open guide ↗A practical recovery map for mastectomy, reconstruction, and gynecologic surgery: drains, garments, sleep, mobility, pain, help at home, and escalation.
Open guide ↗A personalized framework for systemic and local hormone discussions, nonhormone care, bone and heart health, genitourinary symptoms, libido, and sexual recovery.
Open guide ↗A cautious, evidence-led framework: GLP-1 medicines can treat diabetes or obesity in appropriate patients, but they are not established cancer-prevention drugs and microdosing is not a standard protocol.
Open guide ↗A modality-by-modality evidence and safety screen for supportive cancer care—what may help symptoms, what is emerging, and what should never be presented as cancer treatment.
Open guide ↗Turn a denial or disputed plan into a dated record: policy language, medical necessity, network adequacy, authorization, external review, deadlines, and separate clinical and legal opinions.
Open guide ↗A stage-by-stage command center: diagnosis, decision, preauthorization, pre-op, discharge, pathology, recovery, menopause, surveillance, and dispute escalation.
Open guide ↗Cancer and postsurgical pain deserve a named owner, a cause-specific plan, medication and nonmedication options, functional goals, side-effect monitoring, and urgent escalation instructions.
NCI cancer-pain guidanceEvidence is indication- and protocol-specific. Photobiomodulation has supportive-care evidence in defined oral-mucositis settings; that does not make consumer red-light devices a cancer prevention or cancer treatment.
MASCC/ISOO evidence reviewEvery product is screened for regulatory status, exact indication, human evidence, source, interactions, monitoring, and oncology clearance. “Peptide” is a molecule class—not proof of safety or efficacy.
FDA compounded-drug risksMay be considered by a qualified clinician for selected vasomotor or pain-related indications. It is invasive, evidence remains limited, and it is not cancer treatment or prevention.
May be appropriate for selected radiation injury or wound complications under defined criteria—not routine recovery, wellness, or a cancer cure.
Trauma-informed psychotherapy and trained hypnotherapy may support distress, procedural anxiety, pain, or hot flashes. Credentials and the exact therapeutic goal matter.
Gentle practices can support regulation, mobility, and function. Intensity must reflect treatment, anemia, bone health, wounds, drains, and postoperative restrictions.
May support short-term relaxation or symptom relief. Avoid incisions, drains, infected or irradiated tissue, lymphedema-risk areas, and irritating oils without clearance.
Approved medicines can treat diabetes or obesity in appropriate patients. They are not established cancer-prevention drugs; “microdosing” is not a standard FDA-approved protocol.
No light device, peptide, supplement, or wellness protocol should delay diagnosis, surgery, systemic therapy, radiation, or symptom evaluation. Active-cancer and treatment-area use should be cleared with the oncology team.
Selected education from cancer centers, academic medical centers, and radiology organizations. Links open on the publisher’s site. They are not endorsements and do not replace the instructions of the treating team.
A clinical overview to watch before a counseling appointment.
Watch externally ↗Useful context for a family conversation.
Watch externally ↗A specialist panel on screening and preventive surgery; longer-form but chapter-friendly.
Watch externally ↗A focused explanation of surgical menopause.
Watch externally ↗A brief surgical overview.
Watch externally ↗A concise introduction to DIEP reconstruction.
Watch externally ↗A comparison-oriented reconstruction discussion.
Watch externally ↗A short procedure and preparation explainer.
Watch externally ↗A radiologist explains lymphoscintigraphy.
Watch externally ↗Use only with the operating team’s instructions.
Watch externally ↗An original recovery collection is in preparation. It will include only products the business is authorized to sell, with the manufacturer, regulatory status, intended use, instructions, warranty, returns, and any financial relationship clearly disclosed.
Current statusProduct selection and compliance review · checkout not yet active
A portable red-light / photobiomodulation device will be considered only after the exact model, FDA status, labeled indications, instructions, contraindications, and advertising claims are verified. It will not be marketed to prevent, treat, or cure cancer.
Requires surgeon or oncology clearance before treatment-area useSoft front-opening shirt or robe, pull-on bottom, and accessible interior drain pockets. No claim that clothing prevents complications.
Fit + fiber + wash instructions requiredSecure pouches, belt, and shower support designed to reduce pulling and keep bulbs visible. Hospital technique and drain instructions remain controlling.
Accessory—not medical careSeat-belt pillow, wedge or support pillow, nonslip socks, and a compact appointment tote selected for cleanability and practical use.
Comfort—not wound treatmentOriginal appointment agenda, drain and symptom log, medication sheet, family testing map, records index, insurer call log, and questions by stage.
Educational planning tools01AuthorizationReseller or distribution rights for every branded product.
02SubstantiationEvery express and implied health claim reviewed against competent evidence.
03Consumer termsPrice, shipping, tax, returns, warranty, privacy, accessibility, and customer support published before checkout.
04IndependenceProduct purchases never determine professional advice, referrals, or access to legal services.
The collaboration model brings attorney-led decision architecture together with separately licensed clinical professionals. Roles, credentials, conflicts, and responsibility must be explicit so no patient is left guessing who is providing which advice.
Ovarian and fallopian-tube risk, preventive surgery timing, operative options, pathology, residual risk.
High-risk surveillance, risk-reducing mastectomy, reconstruction coordination, second opinions, recovery.
Test selection, report interpretation, informed consent, family cascade testing, reclassification follow-up.
Hormone and nonhormone treatment, bone and heart health, genitourinary care, pain, function, quality of life.
Clinical resources are in place across the specialties described above, including advanced breast-surgery expertise for counseling before, during, and after a surgical course. Individual clinician names are not published on this site. This practice does not perform, schedule, or provide surgery. Any clinical consultation or opinion is independently provided and separately engaged; the law corporation does not control clinical judgment, medical records, diagnosis, treatment, coding, or billing.
Each paid engagement is built around a specific decision, a bounded scope, and a written deliverable. Medical consultations, when available, are provided only through appropriately licensed professionals and a clearly disclosed engagement structure.
Attorney-led intensive
Translate the genetic report, family context, clinical decisions, records, deadlines, and access barriers into a single coordinated plan.
Family strategy
Organize the pedigree, exact familial variant, adult relatives to contact, testing questions, family communication, privacy, and insurance considerations.
Preventive surgery
Prepare for gynecologic-oncology and breast-surgery consultations with a comparison matrix, surgeon questions, second-opinion record, and recovery priorities.
Whole-person care
Map symptoms, bone and cardiovascular care, sexual and genitourinary health, pain, work, caregiving, and the questions for each treating clinician.
Targeted review
Distill the record into a focused clinical question, document conflicts in recommendations, identify missing evidence, and prepare the file for an independently engaged licensed reviewing clinician.
Coverage + dispute
Analyze a denial, authorization failure, network problem, or claim dispute; organize the medical-policy record; and prepare for grievance, appeal, or appropriate external review.
Fixed scopeStrategy intensives and defined written reviews
Bespoke projectComplex surgery, family, rights, or coverage matters
Ongoing counselMonthly advisory support after conflicts and scope review
California attorney · principal legal counsel · bespoke decision strategist
The practice is designed for people who want the full record studied, the hard questions asked, and the next steps made explicit. Suzanne’s role is legal judgment, research, advocacy, and decision architecture across medicine, insurance, employment, privacy, family responsibility, and informed consent—not the practice of medicine.
California consultations by appointment
Begin with a brief telephone or email inquiry. Do not send confidential, medical, genetic, or privileged material before conflicts review and written intake instructions. An inquiry does not create an attorney-client, physician-patient, or other professional relationship.
01Have ready The exact genetic report and a short list of the decisions you are facing. Do not transmit records before intake instructions.
02Name the priority Ovarian risk, breast surgery, family testing, menopause, pain, access, coverage, or legal rights.
03Conflicts first Legal representation begins only after conflicts review and a written engagement agreement.
04Clinical boundary Diagnosis, treatment, prescribing, and surgical recommendations remain with independently licensed treating professionals.
This website is attorney advertising and educational information. Suzanne E. Rand-Lewis, California State Bar No. 126219, is responsible for its legal-services content. No result is promised or guaranteed. Prior results, if ever discussed, do not predict a future outcome. Legal services are limited to matters accepted in writing and within the agreed scope.
This site does not presently offer a practice-operated intake form or use practice-selected advertising pixels. The hosting service may process technical information needed to operate and secure the site. Do not send medical records, genetic reports, confidential facts, or other sensitive information through an unsolicited electronic message. Call first for conflicts screening and secure intake instructions.
This site is not a medical service, does not establish a physician-patient relationship, and is not monitored for emergencies. Clinical professionals retain independent judgment and responsibility for their own services. Call 911 for an apparent emergency and use the treating oncology team’s urgent-care instructions for new or worsening symptoms.
No product checkout is active. Any future product or affiliate relationship will be identified near the relevant link or offer. Product descriptions will state the intended use and will not claim to prevent, treat, or cure cancer unless that exact claim is lawfully authorized and adequately substantiated. Buying a product will never be required to obtain legal services and will not control professional advice. Manufacturer instructions and the treating team’s directions remain controlling.
Stellate ganglion block, hyperbaric oxygen, photobiomodulation, peptides, GLP-1 medicines, massage, aromatherapy, hypnosis, breathwork, movement, and other supportive approaches vary widely in evidence, regulation, risk, and indication. Their inclusion for discussion is not an endorsement or individualized recommendation. No approach should delay standard cancer evaluation or treatment.